Bullous pemphigoid is a potentially debilitating autoimmune bullous disease presenting with urticarial plaques, subepidermal bullae, erosions, and pruritus, classically in elderly individuals.

Charo's husband Kjell Rasten was suffering from bullous pemphigoid prior to his death Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering everything from the NFL to tennis to Simone ...

This elevated risk equated to a bullous pemphigoid incidence rate of 0.42 among DPP-4 inhibitor users versus 0.31 for sulfonylurea users per 1,000 person-years, they wrote in JAMA Dermatology.

The US Food and Drug Administration (FDA) has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid (BP), a condition that predominantly ...

Bullous pemphigoid is an autoimmune disease in which the person's immune system produces antibodies against the skin. It is not infectious. When the antibodies attack, the skin separates.

Bullous pemphigoid is a rare autoimmune disease that causes painful chronic blisters and welts. it typically strikes elderly people who already have one or more diseases or are in poor health.

Pemphigoid disease is most commonly seen in the elderly. Any bullous eruption on the extremities should alert the clinician to consider autoimmune pemphigoid disease.

Patients with mucous membrane pemphigoid should be monitored by a multidisciplinary team due to a risk for malignancy, according to a study.“Mucous membrane pemphigoid (MMP) comprises a ...

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid Approval based on pivotal results showing improvements in ...

Pemphigoid gestationis (PG) is a very rare pregnancy-associated autoimmune skin disease that is characterized by an itchy rash that progresses to form blisters. Initially, the rash appears around ...

Patients with moderate-to-severe bullous pemphigoid were randomly assigned to receive Dupixent 300 mg (53 individuals) or placebo (53 individuals) added to standard-of-care oral corticosteroids.

The FDA approved Dupixent for the treatment of adults with bullous pemphigoid, a rare skin disease often uncontrolled with systemic corticosteroids, Sanofi and Regeneron announced. The FDA’s ...